N G Industries Ltd
₹ 160
1.43%
21 May
10:07 a.m.
About
Incorporated in 1994, N G Industries Ltd is in the business of Healthcare services[1]
Key Points
- Market Cap ₹ 53.6 Cr.
- Current Price ₹ 160
- High / Low ₹ 206 / 145
- Stock P/E 4.42
- Book Value ₹ 124
- Dividend Yield 2.19 %
- ROCE 6.50 %
- ROE 5.63 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 27.4%
Cons
- The company has delivered a poor sales growth of -0.91% over past five years.
- Tax rate seems low
- Company has a low return on equity of 6.20% over last 3 years.
- Earnings include an other income of Rs.13.1 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
14 | 14 | 15 | 17 | 17 | 17 | 18 | 18 | 12 | 18 | 19 | 17 | 16 | |
11 | 11 | 12 | 14 | 14 | 14 | 15 | 16 | 11 | 16 | 17 | 15 | 14 | |
Operating Profit | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 1 | 2 | 2 | 2 | 2 |
OPM % | 21% | 20% | 18% | 18% | 17% | 18% | 16% | 15% | 11% | 13% | 10% | 12% | 11% |
1 | 1 | 1 | -0 | -0 | -0 | -0 | -0 | 0 | 2 | 8 | 5 | 13 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 |
Profit before tax | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 3 | 10 | 6 | 14 |
Tax % | 27% | 28% | 27% | 37% | 36% | 34% | 35% | 28% | 25% | 21% | 14% | 14% | |
2 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 3 | 8 | 5 | 12 | |
EPS in Rs | 6.21 | 4.54 | 4.27 | 4.57 | 4.24 | 4.21 | 3.34 | 4.39 | 1.82 | 7.79 | 24.83 | 15.01 | 36.17 |
Dividend Payout % | 56% | 77% | 82% | 77% | 83% | 83% | 105% | 0% | 0% | 45% | 14% | 23% |
Compounded Sales Growth | |
---|---|
10 Years: | 2% |
5 Years: | -1% |
3 Years: | 12% |
TTM: | -5% |
Compounded Profit Growth | |
---|---|
10 Years: | 2% |
5 Years: | 5% |
3 Years: | 41% |
TTM: | 185% |
Stock Price CAGR | |
---|---|
10 Years: | 8% |
5 Years: | 27% |
3 Years: | 32% |
1 Year: | 1% |
Return on Equity | |
---|---|
10 Years: | 9% |
5 Years: | 7% |
3 Years: | 6% |
Last Year: | 6% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Reserves | 11 | 11 | 11 | 11 | 9 | 8 | 8 | 6 | 12 | 21 | 25 | 33 | 38 |
5 | 2 | 1 | 1 | 2 | 1 | 1 | 3 | 0 | 1 | 1 | 1 | 1 | |
2 | 2 | 2 | 2 | 0 | 0 | 1 | 2 | 2 | 3 | 2 | 3 | 5 | |
Total Liabilities | 20 | 18 | 17 | 17 | 14 | 14 | 13 | 14 | 17 | 27 | 31 | 40 | 48 |
6 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 5 | 6 | 6 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 10 | 8 | 8 | 9 | 4 | 4 | 3 | 4 | 8 | 16 | 22 | 29 | 39 |
4 | 4 | 3 | 3 | 5 | 4 | 5 | 5 | 4 | 5 | 3 | 5 | 4 | |
Total Assets | 20 | 18 | 17 | 17 | 14 | 14 | 13 | 14 | 17 | 27 | 31 | 40 | 48 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | 2 | 2 | 2 | 2 | 2 | 4 | 3 | 1 | -2 | 3 | -1 | |
-4 | 2 | -1 | -1 | -1 | -2 | -1 | -3 | 2 | 1 | -2 | 2 | |
2 | -4 | -2 | -1 | -1 | -2 | -2 | 0 | -3 | 0 | -1 | -1 | |
Net Cash Flow | 0 | 0 | -1 | -0 | 0 | -1 | 1 | -0 | 1 | -0 | 0 | 1 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 2 | 2 | 5 | 6 | 9 | 10 | 11 | 9 | 10 | 15 | 1 | 3 |
Inventory Days | 61 | 65 | 54 | 56 | 61 | 58 | 53 | 41 | 65 | 156 | 35 | 53 |
Days Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash Conversion Cycle | 63 | 67 | 59 | 62 | 70 | 68 | 64 | 51 | 75 | 171 | 36 | 56 |
Working Capital Days | -18 | -23 | -17 | -10 | 26 | 23 | 7 | -8 | -25 | 21 | -13 | 0 |
ROCE % | 16% | 14% | 11% | 18% | 17% | 19% | 19% | 20% | 7% | 11% | 7% | 6% |
Documents
Announcements
-
Board Meeting Intimation for Consideration And Approval Of
1. Audited Financial Results Of The Company For The Quarter And Year Ended 31St March, 2025 And
2. Dividend For The Financial Year Ended 31St March, 2025 Subject To Approval Of The Shareholders At The Ensuing AGM.
9h - Board meeting on May 27 to approve FY25 audited results and consider final dividend recommendation.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
9 Apr - Certificate under Regulation 74(5) for Q1 2025.
- Closure of Trading Window 25 Mar
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
12 Feb - Publication of Unaudited Financial Results for the quarter and nine months ended 31st December, 2024
-
Disclosure Under Regulation 30(5) Of SEBI (LODR) Regulations, 2015 - Authorization To KMPS For Determining Materiality Of An Event And Making Disclosures
11 Feb - Authorization of officials for materiality disclosures.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
Company provides comprehensive healthcare services ranging from Clinics, Diagnostics, Inpatient & Outpatient Services, Pharmacy dispensing, etc.